KMTS (KMTS) Stock Price & Analysis
KMTS (KMTS) rose 0.00% to USD 21.06 as of July 26, 2026 at 08:57 UTC, according to Nexqual real-time market data.
KMTS last closed at USD 21.06; the session ranged USD 20.89–21.9 on volume of 170,305 shares. Market capitalization is —, with a 52-week range of USD 14.1–30 (NMS). Source: Nexqual, July 26, 2026 at 08:57 UTC.
Key Statistics (as of July 26, 2026 at 08:57 UTC)
| Price | USD 21.06 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 21.06 |
| Open | USD 21.06 |
| Day Range | USD 20.89 – 21.9 |
| 52-Week Range | USD 14.1 – 30 |
| Volume | 170,305 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (KMTS)
Nexqual's technical model rates KMTS "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 26, 2026 at 08:57 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 40.29 (neutral) |
| vs SMA50 | Below (USD 22.22) |
| MACD | -0.23 (negative) |
From KMTS's Latest SEC 10-K Filing (filed 2026-07-14)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BBNX | Beta Bionics, Inc. | USD 15.85 | ▼ 2.82% |
| CBLL | CeriBell, Inc. | USD 16.91 | ▲ 0.54% |
| HTFL | Heartflow, Inc. | USD 24.12 | ▼ 0.45% |
| CARL | Carlsmed, Inc. | USD 10.8 | ▼ 2% |
| MAZE | Maze Therapeutics, Inc. | USD 27.68 | ▼ 2.84% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 26, 2026 at 08:57 UTC. This page is informational and not investment advice.